BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22034883)

  • 1. Automated digital volume measurement of melanoma metastases in sentinel nodes predicts disease recurrence and survival.
    Riber-Hansen R; Nyengaard JR; Hamilton-Dutoit SJ; Sjoegren P; Steiniche T
    Histopathology; 2011 Sep; 59(3):433-40. PubMed ID: 22034883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic melanoma volume in sentinel nodes: objective stereology-based measurement predicts disease recurrence and survival.
    Riber-Hansen R; Nyengaard JR; Hamilton-Dutoit SJ; Sjoegren P; Steiniche T
    Histopathology; 2009 Jun; 54(7):796-803. PubMed ID: 19635098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic information from sentinel lymph node biopsy in patients with thick melanoma.
    Scoggins CR; Bowen AL; Martin RC; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; Hagendoorn L; McMasters KM
    Arch Surg; 2010 Jul; 145(7):622-7. PubMed ID: 20644123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional recurrence after negative sentinel lymph node biopsy for melanoma.
    Carlson GW; Page AJ; Cohen C; Parker D; Yaar R; Li A; Hestley A; Delman KA; Murray DR
    Ann Surg; 2008 Sep; 248(3):378-86. PubMed ID: 18791358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis.
    Roka F; Kittler H; Cauzig P; Hoeller C; Hinterhuber G; Wolff K; Pehamberger H; Diem E
    Br J Cancer; 2005 Feb; 92(4):662-7. PubMed ID: 15700039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of drainage and recurrence following sentinel lymph node biopsy for cutaneous melanoma of the head and neck.
    Fincher TR; O'Brien JC; McCarty TM; Fisher TL; Preskitt JT; Lieberman ZH; Stephens JF; Kuhn JA
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):844-8. PubMed ID: 15262761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
    Zogakis TG; Essner R; Wang HJ; Foshag LJ; Morton DL
    Ann Surg Oncol; 2007 May; 14(5):1604-11. PubMed ID: 17333418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
    Gutzmer R; Al Ghazal M; Geerlings H; Kapp A
    Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total sentinel lymph node tumor size predicts nonsentinel node metastasis and survival in patients with melanoma.
    Cadili A; Scolyer RA; Brown PT; Dabbs K; Thompson JF
    Ann Surg Oncol; 2010 Nov; 17(11):3015-20. PubMed ID: 20552405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C
    Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodal distribution, stage migration due to diameter measurement and the prognostic significance of metastasis volume in melanoma sentinel lymph nodes: a validation study.
    Riber-Hansen R; Hamilton-Dutoit SJ; Steiniche T
    APMIS; 2014 Oct; 122(10):968-75. PubMed ID: 24628500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of regional lymph node metastases in patients with melanoma less than 1.0 mm thick: recommendations for sentinel lymph node biopsy.
    Zapas JL; Coley HC; Beam SL; Brown SD; Jablonski KA; Elias EG
    J Am Coll Surg; 2003 Sep; 197(3):403-7. PubMed ID: 12946795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
    Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognosis after sentinel node biopsy in malignant melanoma].
    Lock-Andersen J; Horn J; Sjøstrand H
    Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.